The Joint Corp. (NASDAQ:JYNT) Shares Acquired by Barclays PLC

Barclays PLC lifted its stake in shares of The Joint Corp. (NASDAQ:JYNT) by 71.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,609 shares of the company’s stock after purchasing an additional 10,671 shares during the quarter. Barclays PLC owned about 0.17% of Joint worth $294,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in JYNT. FMR LLC raised its position in shares of Joint by 38.0% during the 3rd quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after purchasing an additional 2,971 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Joint during the 2nd quarter worth approximately $144,000. Sargent Investment Group LLC acquired a new stake in shares of Joint during the 2nd quarter worth approximately $150,000. XTX Topco Ltd acquired a new stake in shares of Joint during the 2nd quarter worth approximately $174,000. Finally, BNP Paribas Financial Markets grew its holdings in Joint by 5.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock worth $258,000 after buying an additional 1,156 shares in the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

Joint Price Performance

Shares of JYNT stock opened at $10.64 on Monday. The Joint Corp. has a 12-month low of $8.88 and a 12-month high of $17.82. The firm has a market capitalization of $159.43 million, a price-to-earnings ratio of -9.33 and a beta of 1.60. The business has a 50 day simple moving average of $11.15 and a 200 day simple moving average of $11.83.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on JYNT. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Friday, November 15th. Roth Mkm decreased their price objective on Joint from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, November 8th.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.